ZA965101B - Blood-pool imaging compositions use and method - Google Patents

Blood-pool imaging compositions use and method

Info

Publication number
ZA965101B
ZA965101B ZA965101A ZA965101A ZA965101B ZA 965101 B ZA965101 B ZA 965101B ZA 965101 A ZA965101 A ZA 965101A ZA 965101 A ZA965101 A ZA 965101A ZA 965101 B ZA965101 B ZA 965101B
Authority
ZA
South Africa
Prior art keywords
compositions
circulation
mixed micelles
blood
mri
Prior art date
Application number
ZA965101A
Other languages
English (en)
Inventor
Herve Tournier
Bernard Lamy
Roland Hyacinthe
Original Assignee
Bracco Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8221760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA965101(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bracco Research Sa filed Critical Bracco Research Sa
Publication of ZA965101B publication Critical patent/ZA965101B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA965101A 1995-06-15 1996-06-14 Blood-pool imaging compositions use and method ZA965101B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810403 1995-06-15

Publications (1)

Publication Number Publication Date
ZA965101B true ZA965101B (en) 1997-01-22

Family

ID=8221760

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA965101A ZA965101B (en) 1995-06-15 1996-06-14 Blood-pool imaging compositions use and method

Country Status (13)

Country Link
US (1) US5833948A (ja)
EP (1) EP0804251B1 (ja)
JP (1) JP4335976B2 (ja)
KR (1) KR100399712B1 (ja)
AT (1) ATE224737T1 (ja)
AU (1) AU708328B2 (ja)
CA (1) CA2195633C (ja)
DE (1) DE69623929T2 (ja)
ES (1) ES2180784T3 (ja)
NO (1) NO314127B1 (ja)
PT (1) PT804251E (ja)
WO (1) WO1997000087A1 (ja)
ZA (1) ZA965101B (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1297034B1 (it) * 1997-12-30 1999-08-03 Bracco Spa Acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
IT1297035B1 (it) * 1997-12-30 1999-08-03 Bracco Spa Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
EP2286843A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
US20070128253A1 (en) * 2005-04-13 2007-06-07 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US20060073197A1 (en) * 2004-05-20 2006-04-06 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US6803046B2 (en) 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
US20050130892A1 (en) * 2003-03-07 2005-06-16 Xencor, Inc. BAFF variants and methods thereof
US20050221443A1 (en) * 2003-01-06 2005-10-06 Xencor, Inc. Tumor necrosis factor super family agonists
US20060014248A1 (en) * 2003-01-06 2006-01-19 Xencor, Inc. TNF super family members with altered immunogenicity
US7553930B2 (en) * 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
EP1590006B1 (en) 2003-02-04 2010-09-08 Bracco Suisse SA Ultrasound contrast agents and process for the preparation thereof
EP2327723A3 (en) 2003-10-10 2012-06-27 Xencor, Inc. Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
CA2547024C (en) 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
US20050152842A1 (en) * 2003-12-24 2005-07-14 Chun Li Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent
CN1960707B (zh) * 2004-06-03 2012-11-14 博莱科瑞士股份有限公司 用于治疗和/或诊断用途的脂质集合体
WO2006018433A1 (en) 2004-08-18 2006-02-23 Bracco Research Sa Gas-filled microvesicles composition for contrast imaging
FR2883562B1 (fr) 2005-03-24 2009-02-27 Guerbet Sa Chelates lipophiles et leur utilisation en imagerie
KR20080009682A (ko) * 2005-04-01 2008-01-29 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 킬레이트제인 폴리(펩티드): 제조 방법과 용도
EP1898958A2 (en) * 2005-05-31 2008-03-19 INBIOS S.r.l. Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine
US20090053197A1 (en) * 2006-06-14 2009-02-26 Ramaekers Joseph C Transfer Factor Compositions and Methods
US9125874B2 (en) 2007-11-30 2015-09-08 The Ramaekers Family Trust Administration of transfer factor for improving reproductive health
US9446156B2 (en) 2006-09-05 2016-09-20 Bracco Suisse S.A. Gas-filled microvesicles with polymer-modified lipids
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
US20090074751A1 (en) * 2007-09-18 2009-03-19 Ramaekers Nutrition, Inc. Growth factor fraction compositions and methods
KR101401217B1 (ko) * 2007-11-07 2014-05-28 충남대학교산학협력단 Pe-dtpa의 새로운 용도
US8946148B2 (en) 2007-11-20 2015-02-03 Ambrx, Inc. Modified insulin polypeptides and their uses
EP2278984A4 (en) * 2007-11-30 2013-02-27 Ramaekers Family Trust COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY
SG10201906494PA (en) 2008-01-30 2019-09-27 Histogen Inc Extracellular matrix compositions
CN102341126A (zh) * 2009-02-13 2012-02-01 华盛顿大学 用于磁共振成像的钆表现脂质纳米颗粒
WO2010139003A1 (en) * 2009-06-01 2010-12-09 Commonwealth Scientific And Industrial Research Organisation Chelating amphiphiles
SG10201506443TA (en) 2010-08-17 2015-10-29 Ambrx Inc Modified relaxin polypeptides and their uses
EP2639227A1 (en) 2012-03-14 2013-09-18 Bracco Imaging S.p.A A new class of diazepine derivative chelating agents and complexes with paramagnetic metals as MRI contrast agents
US10039843B2 (en) 2012-09-07 2018-08-07 Bracco Imaging S.P.A. Paramagnetic solid lipid nanoparticles (pSLNs) containing metal amphiphilic complexes for MRI
US11365229B2 (en) 2012-09-10 2022-06-21 Xencor, Inc. Methods of treating neurological diseases
JP6313329B2 (ja) 2012-12-21 2018-04-18 ブラッコ・スイス・ソシエテ・アノニムBracco Suisse SA ガス封入マイクロベシクル
WO2015119642A1 (en) 2014-02-10 2015-08-13 The Johns Hopkins University Low oxygen tension enhances endothelial fate of human pluripotent stem cells
US10519207B2 (en) 2015-06-12 2019-12-31 Georgia State University Research Foundation, Inc. Compositions and methods for treating opioid tolerance
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
US12077780B2 (en) 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387410A (en) * 1983-03-18 1995-02-07 Mallinckrodt, Inc. Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging
US5215680A (en) * 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
WO1992021017A1 (en) * 1991-05-23 1992-11-26 Unger Evan C Liposoluble compounds for magnetic resonance imaging
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US5567410A (en) * 1994-06-24 1996-10-22 The General Hospital Corporation Composotions and methods for radiographic imaging

Also Published As

Publication number Publication date
KR970704477A (ko) 1997-09-06
JP4335976B2 (ja) 2009-09-30
WO1997000087A1 (en) 1997-01-03
CA2195633C (en) 2008-09-16
PT804251E (pt) 2003-01-31
US5833948A (en) 1998-11-10
NO314127B1 (no) 2003-02-03
EP0804251A1 (en) 1997-11-05
ES2180784T3 (es) 2003-02-16
AU708328B2 (en) 1999-08-05
DE69623929D1 (de) 2002-10-31
DE69623929T2 (de) 2003-05-15
JPH10504044A (ja) 1998-04-14
KR100399712B1 (ko) 2004-02-18
NO970665L (no) 1997-04-03
AU5843196A (en) 1997-01-15
ATE224737T1 (de) 2002-10-15
EP0804251B1 (en) 2002-09-25
NO970665D0 (no) 1997-02-13
CA2195633A1 (en) 1997-01-03

Similar Documents

Publication Publication Date Title
ZA965101B (en) Blood-pool imaging compositions use and method
IL125895A0 (en) The use of an image enhancing moiety in the preparation of bioactivated nmr or optical imaging contrat agent from a prodrug
Yamamoto et al. A clinicopathologic study of transient osteoporosis of the hip
WO2003061466A3 (en) Method and apparatus for evaluation of contrast agent uptake based on derived parametric images
EP0994352A3 (en) Contrast agent enhanced magnetic resonance imaging of myocardial tissue
ES2152932T3 (es) Particulas de apatita tratadas para tecnicas de imagen para diagnostico medico.
Chin et al. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants
Vandevenne et al. Reduction of metal artefacts in musculoskeletal MR imaging
GB9716365D0 (en) Improvements in or relating to magnetic resonance imaging
IL117248A (en) Liposome suspensions as carriers of blood-pool imaging contrast agents and methods for preparing the same
Gorospe et al. Ewing’s sarcoma of the mandible: radiologic features with emphasis on magnetic resonance appearance
Lutsep et al. Does reversal of ischemia on diffusion‐weighted imaging reflect higher apparent diffusion coefficient values?
CN114848678B (zh) 龟板在制备治疗脑衰老的药物中的应用
Sbarbati et al. Effect of dietary supplementation with zinc sulphate on the aging process: a study using high field intensity MRI and chemical shift imaging
Lewin Technological innovations and discoveries in the
Gates et al. Neuroimaging of fractureless transforamen magnum penetrating injury of the cerebellum
LODGE et al. Reproducibility of quantitative permeability measurements in dynamic contrast-enhanced MRI studies
Ravsten et al. Ex vivo Bio-orthogonal MRI imaging–A novel method proposed for metastatic cancer detection
Friedrich et al. Noninvasive diagnosis of acute myocarditis by contrast-enhanced magnetic resonance imaging
Milman et al. Improved correlation between diffusion parameters and cell volume fraction in high-resolution diffusionweighted images
Sumida et al. Development of the pineal gland: measurement with MR imaging
Tsuchimochi MR imaging of canine salivary glands after ductal ligation and stimulation by pilocarpine
Lee et al. Amide proton transfer-weighted MR imaging in the rat brain of demyelination and remyelination
Niehoff et al. Electron beam portal imaging for routine documentation in radiation therapy
Grafton et al. PM Corballis, PhD; S. Inati, PhD; MG Funnell, PhD